2.94
7.92%
0.2157
プレマーケット:
3.00
0.06
+2.04%
前日終値:
$2.7243
開ける:
$2.82
24時間の取引高:
23,751
Relative Volume:
0.51
時価総額:
$76.69M
収益:
$6.21M
当期純損益:
$-19.92M
株価収益率:
-2.80
EPS:
-1.05
ネットキャッシュフロー:
$-16.76M
1週間 パフォーマンス:
+10.11%
1か月 パフォーマンス:
-2.00%
6か月 パフォーマンス:
+24.58%
1年 パフォーマンス:
-5.16%
InspireMD Inc. Stock (NSPR) Company Profile
NSPR を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.94 | 76.69M | 6.21M | -19.92M | -16.76M | -1.05 |
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2016-01-07 | 開始されました | Rodman & Renshaw | Buy |
2015-03-13 | ダウングレード | Oppenheimer | Outperform → Perform |
2013-11-26 | 開始されました | Oppenheimer | Outperform |
InspireMD Inc. (NSPR) 最新ニュース
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Compliance Issues And Stock Developments Hit Nasdaq Companies - Evrim Ağacı
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - Defense World
InspireMD : Breakthrough device in clinical trials aims to prevent strokes -January 20, 2025 at 07:59 am EST - Marketscreener.com
Here's Why We're Watching InspireMD's (NASDAQ:NSPR) Cash Burn Situation - Yahoo Finance
InspireMD (NYSE:NSPR) Coverage Initiated by Analysts at StockNews.com - MarketBeat
InspireMD (NYSE:NSPR) Now Covered by StockNews.com - Defense World
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World
InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - MarketBeat
InspireMD, Inc. CFO Craig Shore to Retire, Company Initiates Search for SuccessorDecember 12, 2024 - Defense World
NSPRInspireMD, Inc. Latest Stock News & Market Updates - StockTitan
Medical device company kicks off search for next CFO - The Business Journals
InspireMD CFO Craig Shore to retire, successor search underway - Investing.com India
InspireMD CFO Retirement Amid Strategic Transition - TipRanks
InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025 - GlobeNewswire
InspireMD CFO to Retire After 15 Years Amid Crucial FDA Approval Timeline for Stroke Prevention Device - StockTitan
NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study - MSN
Lake Street Initiates Coverage of InspireMD (NSPR) with Buy Recommendation - MSN
InspireMD Announces First Patient Enrolled in CGUARDIANS II Pivotal Study - Defense World
Inspiremd Announces First Patient Enrolled in the Cguardians Ii Pivotal Study of the Cguard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures - Marketscreener.com
InspireMD Advances CGuard Prime with New Clinical Trial - TipRanks
InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR) - GlobeNewswire
InspireMD Launches Pivotal CGUARDIANS II Trial for Revolutionary Carotid Stent System - StockTitan
Head to Head Contrast: Penumbra (NYSE:PEN) vs. InspireMD (NYSE:NSPR) - Defense World
InspireMD adds medtech veteran Scott Ward to its board By Investing.com - Investing.com South Africa
InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - Defense World
InspireMD appoints Scott R. Ward to its Board - Medical Buyer
InspireMD Appoints Scott R. Ward to Board of Directors - Defense World
InspireMD, Inc. Appoints Scott R. Ward to Its Board of Directors - Marketscreener.com
InspireMD adds medtech veteran Scott Ward to its board - Investing.com
InspireMD Strengthens Leadership with Scott R. Ward Appointment - TipRanks
InspireMD Announces Appointment of Accomplished Medical - GlobeNewswire
InspireMD Strengthens Board with Ex-Medtronic Executive Ahead of CGuard Prime FDA Decision | NSPR Stock News - StockTitan
InspireMD Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.15 loss in 3Q 2023) - Simply Wall St
InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates - MSN
InspireMD Inc (NSPR) Quarterly 10-Q Report - Quartzy
InspireMD, Inc. (NASDAQ:NSPR) Q3 2024 Earnings Call Transcript - Insider Monkey
InspireMD Inc. Faces Financial Uncertainty Amidst Ongoing Losses and Cash Flow Challenges - TipRanks
InspireMD Inc. Reports Q3 2024 Financial Results - TipRanks
InspireMD Achieves Record Q3 Revenue with CGuard Success - TipRanks
InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
InspireMD Sets Revenue Record, Files FDA Approval for CGuard Stent Amid Wider Losses | NSPR Stock News - StockTitan
What To Expect From InspireMD Inc (NSPR) Q3 2024 Earnings - Yahoo Finance
InspireMD announces inducement grants - Medical Buyer
InspireMD Inc. (NSPR) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):